Navigation Links
GlaxoSmithKline and Pfizer Announce Innovative Agreement to Create a New World-Leading, Specialist HIV Company
Date:4/16/2009

Business Unit, Europe, Pfizer
  • Zhi Hong, SVP and Head of Infectious Diseases CEDD, GSK
  • Abbas Hussain, President Emerging Markets, GSK
  • Duncan Learmouth, SVP Corporate Communications & Community Partnerships, GSK
  • Martin Mackay, President, Global Research & Development, Pfizer
  • Ian McCubbin, SVP Strategy, Logistics and External Supply, GSK
  • Ellen Strahlman, SVP and Chief Medical Officer, GSK

  • GSK and Pfizer have established an integration steering committee, with representatives from both companies to prepare for the operation of the new company upon the closing of the transaction. A head of R&D will be appointed to oversee all research and development activities. Manufacturing and other services will be provided by GSK and Pfizer.

    Financial details

    The combination is highly complementary and serves both companies strategically. For GSK, the transaction will expand its marketed portfolio, helping to reduce the impact of patent expiries to several of its HIV products in future years, and it will provide access to a broad range of new pipeline assets. For Pfizer, the collaboration will provide Selzentry/Celsentri and its pipeline assets with access to GSK's global HIV commercial organisation and HIV distribution network to better reach patients in need.

    Equity interests

    Upon completion of the transaction, GSK will hold an 85% equity interest in the new company and Pfizer will hold 15% reflecting the value of their currently marketed products. To reflect the potential future performance of their respective HIV pipeline products, GSK and Pfizer have agreed a structure for their equity interests to be adjusted in the event that specified sales and regulatory milestones are achieved.

    If all milestones were to be achieved, GSK's equity interest in th
    '/>"/>

    SOURCE GlaxoSmithKline plc
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. GlaxoSmithKline and Shire Enter Agreement to Co-Promote Vyvanse(R) (lisdexamfetamine dimesylate) CII for Adult Attention Deficit Hyperactivity Disorder
    2. IADR and GlaxoSmithKline Consumer Healthcare announce winners of 2009 Innovation in Oral Care Awards
    3. GlaxoSmithKline Consumer Healthcare to Reach 85 Percent of the Worlds Smokers with Quit Aids
    4. GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
    5. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
    6. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
    7. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
    8. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
    9. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
    10. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
    11. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
    (Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
    (Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
    (Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
    (Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ...
    Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
    ... significantly increased life expectancy in early tests of patients ... aggressive form of brain cancer in adults − is ... Clinic in Jacksonville. , The vaccine represents a fresh ... neurosurgeon Kent New, M.D., Ph.D., who will be leading ...
    ... Looks toward Year of Continued Rapid Growth For Retail ... ... Web Golinkin, president and CEO,of RediClinic, LLC, has been elected president ... Care,Industry (CCI). A founder of the association and its first treasurer, ...
    ... to Break Ground, TAMPA, Fla., Oct. 22 The ... of Tampa Bay will break ground in January of,2008, and ... Center of Tampa Bay, developed and operated by Tampa Bay,Radiosurgical ... be used by a large number of physicians from various ...
    ... Medicine, will appear at Sixth & I for a ... sciences and their potential to transform medical treatment. ... scientist in the United Kingdom, where he was born. ... (CDK) as the key regulator molecule controlling the process ...
    ... in the fight against HIV and they must be ... to a new commentary published today in the journal ... London, who are evaluating multiple candidate vaccines designed to ... must commit to sharing technology and expertise with those ...
    ... October 22, 2007 Today, The National Institutes of ... Science Editors global theme issue on poverty and human ... by more than 230 journals worldwide. , Many ... Science Editors campaign to encourage science journals to focus ...
    Cached Medicine News:Health News:Mayo Clinic tests novel vaccine for aggressive brain tumors 2Health News:RediClinic's Web Golinkin to Lead Convenient Care Association 2Health News:Fight against HIV needs local scientists, say researchers 2Health News:Elsevier journals participate widely in global theme issue on poverty and human development 2
    (Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
    (Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
    (Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
    Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
    ... Dec. 14, 2010 The Dr. Paul Janssen ... call for nominations. This prestigious award recognizes individuals ... potential to make, significant transformational contributions toward the ... www.pauljanssenaward.com and will be accepted until ...
    ... The DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments ... to the Space Environment for Technology (FAST) program, at ... Texas, at the end of September.  The rHEALTH sensor ... from a single drop of blood.  Although designed for ...
    Cached Medicine Technology:Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3DNA Medicine Institute Completes Reduced-Gravity Experiments on its NASA-Funded rHEALTH Sensor 2
    ... Corneal Topographer has applications in ... procedures including Radial Keratotomy, Astigmatic ... Lens Fitting. Based on an ... E300 analyses an accurate ring ...
    ... System provides an automated scalable system capable ... SNP genotypes per day. Combined with multiplexing ... enables you to process a wide range ... designed to deliver your intended results faster ...
    ... including fourSight 4D ultrasound imaging technology for ... wide variety of imaging and workflow enhancements ... combine to expand the clinical capabilities for ... was built on four foundations that mark ...
    ... The BeStent2, a laser-cut stent, is the ... stent systems for use after coronary arteries ... a therapy known as percutaneous transluminal coronary ... a number of features designed to optimize ...
    Medicine Products: